3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Hepatoblastoma
5
Ovarian Neoplasms
3
Ototoxicity
3
Gastrointestinal Neoplasms
3
Stomach Neoplasms
2
Sarcoma
2
Liver Neoplasms
2
Testicular Neoplasms
1
Teratoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Necrosis
1
Mesothelioma, Malignant
1
Medulloblastoma
1
Liposarcoma
1
Hearing Loss
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Brain Neoplasms
1
Appendiceal Neoplasms
1
Adenocarcinoma
1
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Melphalan
4
fludarabine
3
Granulocyte Colony-Stimulating Factor
3
Cyclophosphamide
3
Busulfan
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
ensartinib
2
Vemurafenib
2
Trabectedin
2
Thiotepa
2
Temozolomide
2
Sirolimus
2
Mesna
2
LY3023414
2
Cytoreduction Surgical Procedures
2
Cisplatin
2
talazoparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdomyosarcoma
×
sodium thiosulfate
×
Gastrointestinal
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled